06 March 2024
06 March 2024
The biosimilars are authorised to treat all indications of their reference medicines.
The UK Government announced plans to bolster the UK life science manufacturing industry through increased investment.
The merged business will combine the pipelines of both companies, focusing on treatments for cancer and rare diseases.
A new study suggests that Japanese patients with chronic conditions score lower than other developed countries across a range of metrics.
Ono will gain exclusive global rights to NXI-101 and its backup antibodies.
Sonrai's AI platform will be instrumental in examining multi-omics data from studies targeting lung and pancreatic cancer.
Towa Pharmaceutical's patent involves a resin molding apparatus with a unique design for forming cavities in resin materials.
Galecto has been granted a patent for an a-D-galactopyranose compound (formula provided) for treating disorders related to galectin binding in mammals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
